US 8703938
Hepatitis C virus inhibitors
granted A61KA61K31/4025A61K31/427
Quick answer
US patent 8703938 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/4025, A61K31/427, A61K31/444, A61K31/4545